To further examine the involvement of ABCB1 and ABCC11 in the development of eribulin resistance in breast cancer cells, we tested whether knockdown of ABCB1 or ABCC11 would restore eribulin sensitivity in eribulin-resistant breast cancer cells. Here, ABCC11 is linked to breast carcinoma.